Phase II Study of Aldesleukin (IL-2) Following the Administration of Zanolimumab (Anti-CD4mAb) in Metastatic Melanoma and Metastatic Renal Cancer
Condition(s):Metastatic Melanoma; Metastatic Renal CancerLast Updated:October 28, 2015Terminated
Hide Studies Not Open or Pending
Condition(s):Metastatic Melanoma; Metastatic Renal CancerLast Updated:October 28, 2015Terminated
Condition(s):Mycosis Fungoides; Sezary SyndromeLast Updated:July 26, 2012Terminated
Condition(s):Cutaneous T-Cell LymphomaLast Updated:April 28, 2023Completed
Condition(s):Cutaneous T-Cell LymphomaLast Updated:May 18, 2023Completed
Condition(s):Rheumatoid ArthritisLast Updated:April 28, 2023Terminated
Condition(s):T-cell LymphomaLast Updated:October 25, 2023Terminated
Condition(s):T Cell LymphomaLast Updated:March 18, 2024Completed
At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.